The Eurasian Journal of Medicine
Review

A New Target in Inflammatory Diseases: Lycopene

1.

Department of Pharmacology, Erzincan Binali Yildirim University, Faculty of Pharmacy, Erzincan, Turkey

2.

Department of Pharmacology, Ataturk University, Faculty of Medicine, Erzurum, Turkey

Eurasian J Med 2022; 54: Supplement S23-S28
DOI: 10.5152/eurasianjmed.2022.22303
Read: 1419 Downloads: 511 Published: 01 December 2022

nflammation is a response to various injuries, illnesses, and severe trauma. The primary function of inflammation is to combat pathogens, eliminate them from the body, and initiate wound healing. However, inflammation also contributes to numerous diseases, such as cancer, cardiovascular disease, diabetes, obesity, osteoporosis, rheumatoid arthritis, inflammatory bowel disease, and asthma. As the importance of nutrition in maintaining human health has become increasingly recognized, the consumption of natural antioxidants has gained popularity, especially in developed countries. A growing body of research has shown that consuming foods rich in lycopene can protect individuals from a range of conditions, including cancer, heart disease, and other diseases. As a result, lycopene is gaining recognition as a potential protective antioxidant in the fields of medicine and pharmacology. This review aims to highlight the effects of lycopene on inflammatory diseases and provide a foundational understanding for researchers interested in further research on lycopene.

Cite this article as: Karaköy Z, Cadirci E, Dincer B. A new target in inflammatory diseases: Lycopene. Eurasian J Med., 2022;54(Suppl. 1):S23-S28.

Files
EISSN 1308-8742